Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Iowa Medical Journal
|
September 7, 2023
M'Gugin Monument
E R Ford
The Lancet. Oncology
|
June 22, 2014
Gefitinib for oesophageal cancer: a cog in need of a wheel?
Hugo E R Ford
Clinical and Experimental Dermatology
|
May 22, 2009
Localized bilateral lymphoedema of the ear lobes secondary to mesothelioma
V Gudi, S K Chan, C Laroche, et al.
Pharmacoeconomics
|
September 6, 2015
The Cost Effectiveness of Docetaxel and Active Symptom Control versus Active Symptom Control Alone for Refractory Oesophagogastric Adenocarcinoma: Economic Analysis of the COUGAR-02 Trial
David M Meads, Andrea Marshall, Claire T Hulme, et al.
Palliative Medicine
|
May 8, 2012
The role of multi-disciplinary teams in decision-making for patients with recurrent malignant disease
Sean Strong, Natalie S Blencowe, Tom Fox, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 11, 2005
Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control
C L Harper-Wynne, K Sumpter, C Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma
E Andreopoulou, P J Ross, M E R O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2002
Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331
Hugo E R Ford, Fraser Mitchell, David Cunningham, et al.
Cancer Chemotherapy and Pharmacology
|
March 11, 2006
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
Hugo E R Ford, Yoon-Sim Yap, David W Miles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2004
The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer
Ian Chau, Mark J Allen, David Cunningham, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Iowa Medical Journal
|
September 7, 2023
M'Gugin Monument
E R Ford
The Lancet. Oncology
|
June 22, 2014
Gefitinib for oesophageal cancer: a cog in need of a wheel?
Hugo E R Ford
Clinical and Experimental Dermatology
|
May 22, 2009
Localized bilateral lymphoedema of the ear lobes secondary to mesothelioma
V Gudi, S K Chan, C Laroche, et al.
Pharmacoeconomics
|
September 6, 2015
The Cost Effectiveness of Docetaxel and Active Symptom Control versus Active Symptom Control Alone for Refractory Oesophagogastric Adenocarcinoma: Economic Analysis of the COUGAR-02 Trial
David M Meads, Andrea Marshall, Claire T Hulme, et al.
Palliative Medicine
|
May 8, 2012
The role of multi-disciplinary teams in decision-making for patients with recurrent malignant disease
Sean Strong, Natalie S Blencowe, Tom Fox, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 11, 2005
Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control
C L Harper-Wynne, K Sumpter, C Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma
E Andreopoulou, P J Ross, M E R O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2002
Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331
Hugo E R Ford, Fraser Mitchell, David Cunningham, et al.
Cancer Chemotherapy and Pharmacology
|
March 11, 2006
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
Hugo E R Ford, Yoon-Sim Yap, David W Miles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2004
The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer
Ian Chau, Mark J Allen, David Cunningham, et al.
Page
of 2